Medifast: Q4 Earnings Insights

Medifast MED reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Medifast beat estimated earnings by 9.81%, reporting an EPS of $2.91 versus an estimate of $2.65.

Revenue was up $112.92 million from the same period last year.

Last quarter the company beat on EPS by $0.48 which was followed by a 2.92% increase in the share price the next day.

Here's a look at Medifast's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	3.08	3.31	2.73	2.38
EPS Actual	3.56	3.96	3.46	2.36
Revenue Estimate	403.76M	358.45M	278.89M	244.49M
Revenue Actual	413.39M	394.19M	340.67M	264.91M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Medifast management provided guidance for their next quarter, expecting earnings between $14.5 and $16.0 per share for the next quarter.

This represents a 424.05% in quarter-over-quarter growth for Medifast, a bullish signal to many investors.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar